investors.psivida.com

Investors - pSivida - Investor Relations Home

PSivida develops tiny, sustained-release drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. We have developed three of the four products approved in either the U.S. or the EU for sustained release delivery of drug to treat chronic back-of-the-eye diseases utilizing multiple generations of our Durasert. Our lead development product, ILUVIEN. PSivida’s other two FDA-approved products, Retisert. View all ». Jul 21, 2015. Jul 13, 2015.

http://investors.psivida.com/

OVERVIEW OF investors.psivida.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

19

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.PSIVIDA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

June

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 9 reviews

5 star

3

4 star

6

3 star

0

2 star

0

1 star

0

Hey there! Start your review of investors.psivida.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT INVESTORS.PSIVIDA.COM

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

19

SSL

EXTERNAL LINKS

8

SITE IP

206.200.251.19

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Investors - pSivida - Investor Relations Home | investors.psivida.com Reviews

<META> DESCRIPTION

PSivida develops tiny, sustained-release drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. We have developed three of the four products approved in either the U.S. or the EU for sustained release delivery of drug to treat chronic back-of-the-eye diseases utilizing multiple generations of our Durasert. Our lead development product, ILUVIEN. PSivida’s other two FDA-approved products, Retisert. View all ». Jul 21, 2015. Jul 13, 2015.

<META> KEYWORDS

1 psivida corp

2 share this on

3 delicious

4 digg

5 facebook

6 linkedin

7 twitter

8 what is this

9 investor relations home

10 trade;

CONTENT

Page content here

KEYWORDS ON PAGE

psivida corp,share this on,delicious,digg,facebook,linkedin,twitter,what is this,investor relations home,trade;,technology system,and vitrasert,recent releases,ir contacts,beverly jedynak,president,bjedynak@janispr com,transfer agent,info@psivida com,faqs

POWERED BY

ASP.NET

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Investors - pSivida - Investor Relations Home | investors.psivida.com Reviews

https://investors.psivida.com

PSivida develops tiny, sustained-release drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. We have developed three of the four products approved in either the U.S. or the EU for sustained release delivery of drug to treat chronic back-of-the-eye diseases utilizing multiple generations of our Durasert. Our lead development product, ILUVIEN. PSivida’s other two FDA-approved products, Retisert. View all ». Jul 21, 2015. Jul 13, 2015.

INTERNAL PAGES

investors.psivida.com

1

Investors - pSivida - Events & Presentations

http://investors.psivida.com/events.cfm

Feb 17, 2017. Details on upcoming events are not yet available. Feb 14, 2017. 2017 BIO CEO and Investor Conference. Feb 7, 2017. Q2 2017 pSivida Corp. Earnings Conference Call. Nov 7, 2016. Q1 2017 pSivida Corp. Earnings Conference Call. Oct 13, 2016. Ophthalmology Innovation Summit @ AAO. Sep 27, 2016. Ladenburg Thalmann Annual Healthcare Conference. Sep 12, 2016. Q4 2016 pSivida Corp. Earnings Conference Call. May 5, 2016. Q3 2016 pSivida Corp. Earnings Conference Call. Feb 9, 2016. Feb 8, 2016. Q4 201...

2

Investors - pSivida - RSS News Feeds

http://investors.psivida.com/rss.cfm

Really Simple Syndication (RSS) is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates. How do I use RSS? To make use of RSS, you'll need an RSS reader, or aggregator. An RSS aggregator can be a stand-alone application, or a plug-in for another program you already use, such as Microsoft Outlook. Some web browsers, such as Firefox. To view a feed in your RSS Aggregator:.

3

Investors - pSivida - Email Alert Subscription

http://investors.psivida.com/profile.cfm

Step 1 of 3: Select Options. You may automatically receive pSivida Corp. financial information by email. Please enter your preferences for email notifications below and click "Continue" to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here. Quarterly and Annual Reports. All Events and Webcasts. In advance of any event. Send me a stock update at the end of the trading day. Alert me when the stock changes more than.

4

pSivida CEO to Speak at Controlled Release Society Annual Meeting Workshop in Edinburgh, Scotland, This Weekend (NASDAQ:PSDV)

http://investors.psivida.com/releasedetail.cfm?ReleaseID=922976

Laquo; Previous Release. Next Release ». July 21, 2015. PSivida CEO to Speak at Controlled Release Society Annual Meeting Workshop in Edinburgh, Scotland, This Weekend. NASDAQ:PSDV)(ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced Dr. President and CEO of. Will speak at a special workshop focusing on ocular drug delivery just prior to the start of the. CRS) 2015 Annual Meeting being held. Saturday, July 25. By 2018. Yet only ...

5

Investors - pSivida - Press Releases

http://investors.psivida.com/releases.cfm

Topline Results from First Phase 3 Trial of pSivida's Medidur™ Presented at ASRS Annual Meeting. Aug 15, 2016. WATERTOWN, Mass., Aug. 15, 2016 (GLOBE NEWSWIRE) - pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for eye diseases, announced that Dr. Glenn J. Jaffe, Robert Machemer Professor of Ophthalmology at Duke University School of Medicine in Durham, NC and the principal investiga. Aug 9, 2016. Aug 3, 2016. PSivida Corp and Hospit...

UPGRADE TO PREMIUM TO VIEW 14 MORE

TOTAL PAGES IN THIS WEBSITE

19

LINKS TO THIS WEBSITE

psivida.com

Products - pSivida

http://www.psivida.com/products.html

The continued advancement of drug delivery technology is critically important in the drive to both increase efficacy and improve patient safety. Furthermore, the use of novel drug delivery systems is an increasingly important strategy for pharmaceutical and biotechnology companies to enable the delivery of new drugs while also extending the commercial life of their current drugs. Our Durasert Technology enables the development of drug delivery devices that can be:. Administered in an office visit. Click ...

psivida.com

Sustained-release drug delivery systems - pSivida

http://www.psivida.com/about.html

Focused Therapeutics / Visionary Science. PSivida is a leading provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems. Our proven proprietary technologies enable us to achieve highly focused, long-term delivery of therapeutics. We have developed three of the only four products approved by either the US or EU for the long-term, sustained-released delivery of drug to treat chronic eye disease. Additionally, ILUVIEN&reg for diabetic macular edema ...

psivida.com

Careers - pSivida

http://www.psivida.com/careers.html

Working at pSivida Corporation. PSivida is a leader in the development of miniaturized, sustained release drug delivery systems. Our culture is dynamic, cutting edge, and collegial. We are a NASDAQ listed, global company but we have the entrepreneurial focus and energy of a small organization. We offer a comprehensive benefits package and tremendous growth opportunity for individuals with the right experience. We currently have no open positions.

psivida.com

Therapeutic Products, Injectable Drug Delivery - pSivida

http://www.psivida.com/patient-advocacy.html

PATIENT ADVOCACY / DIABETIC MACULAR EDEMA. Diabetic Macular Edema (DME) is one of the largest causes of vision loss in the developed world and is one of several diabetic eye diseases. Diabetic eye disease refers to a group of eye problems that people with diabetes may face as a complication of diabetes. All can cause severe vision loss or even blindness. Diabetic eye disease may include:. Diabetic retinopathy : Damage to the blood vessels in the retina. For more information on Iluvien click here ».

psivida.com

Press Releases - pSivida

http://www.psivida.com/news-events.html

NEWS and EVENTS / PRESS RELEASES. For recent Press Releases click here. For inquires please contact:. Martin E. Janis and Company, Inc. Tel: 617-926-5000 Fax: 617-926-5050 US WEB SITE TERMS AND CONDITIONS.

psivida.com

Sitemap - pSivida

http://www.psivida.com/sitemap.html

Tel: 617-926-5000 Fax: 617-926-5050 US WEB SITE TERMS AND CONDITIONS.

psivida.com

Sustained-release drug delivery systems - pSivida

http://www.psivida.com/index.html

Focused Therapeutics / Visionary Science. PSivida is a leading provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems. Our proven proprietary technologies enable us to achieve highly focused, long-term delivery of therapeutics. We have developed three of the only four products approved by either the US or EU for the long-term, sustained-released delivery of drug to treat chronic eye disease. Additionally, ILUVIEN&reg for diabetic macular edema ...

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

8

SOCIAL ENGAGEMENT

share.php

OTHER SITES

investors.progress.com

Investors | Progress Software Corporation

Skip to main navigation. Application Development and Deployment. Build rich, smart HTML5 and JavaScript apps for any platform, browser or device. Use Angular, TypeScript or JavaScript to build truly native mobile apps. Deliver Awesome UI with the most complete toolboxes for .NET, Web and Mobile development. Automate UI, load and performance testing for web, desktop and mobile. Rapidly develop, manage and deploy business apps, delivered as SaaS in the cloud. Data Connectivity and Integration. Progress par...

investors.progressive.com

Investor Relations - Investor Relations at Progressive

1 Auto Insurance Site. Annual and Quarterly Shareholder Reports. Analyst Coverage and Ratings. Since our beginning in 1937, the Progressive Group of Insurance Companies has been an innovator. We've grown into new markets and pioneered new ways to meet consumers' needs, including offering competitive rates and initiating 24-hour, in-person and online services. As a result, we are one of the largest U.S. private passenger auto insurance groups, with annual premiums over $15 billion. Last trade as of.

investors.proofpoint.com

Proofpoint, Inc. - Investor Relations

Skip to main content. Quarterly and Annual Reports. Stock Quote and Chart. Proofpoint protects people, data, and brands across email, cloud, social media, and mobile devices. We help customers manage critical data and respond quickly when things go wrong. Quarterly and Annual Reports. Stock Quote and Chart. End of Day Stock Quote. Enter the code shown above. Email Alert Sign Up Confirmation. Powered By Q4 Inc. Opens in new window).

investors.propertyware.com

We've got your assets covered.

Welcome to Investors Realty Property Management. We manage some of the areas most desirable rentals. Our progressive staff understands that consistently working to improve the quality of service and attention to detail are the best ways to provide a comfortable lifestyle for the people who have chosen our rentals. Our tenants feel confident knowing that 24 hours a day, 7 days a week they will be able to reach us with a problem and who will promptly address any maintenance issue. 719 North Calhoun St.

investors.psiengines.com

Power Great Lakes, Inc. – Value Added Diesel Engine Distributor – Perkins

Power Great Lakes, Inc. Tier 4 Compliant Diesel. All PGL engines are available as complete packages specifically customized to meet the needs of the application. Our industry-leading engineers design each assembly, sourcing each component according to intended run conditions. Each package is tested and carefully calibrated using sophisticated simulation equipment. PGL transform engines into ruggedized power systems ideally suited to customers end-application use. Power Great Lakes, Inc.

investors.psivida.com

Investors - pSivida - Investor Relations Home

PSivida develops tiny, sustained-release drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. We have developed three of the four products approved in either the U.S. or the EU for sustained release delivery of drug to treat chronic back-of-the-eye diseases utilizing multiple generations of our Durasert. Our lead development product, ILUVIEN. PSivida’s other two FDA-approved products, Retisert. View all ». Jul 21, 2015. Jul 13, 2015.

investors.psychemedics.com

Corporate Profile | Psychemedics

Was successfully added to your cart. No products in the cart. Why Choose PMD Hair. A Message From Our CEO. The Importance of Effective Drug Testing. The Science Behind Hair Analysis. Why Hair Over Urinalysis Testing. All Hair Drug Testing Is Not The Same. SEC Filings and Press Releases. 013) (0.53) %. As of January 12, 2017 11:47 AM ET. Minimum 20 minute delay. 013) (0.53) %. As of January 12, 2017 11:47 AM ET. Minimum 20 minute delay. Psychemedics Corporation Announces Record Revenues and Earnings.

investors.public121.com

Investors

Please Enter Password To Access This Site.Or Contact Us For Password on irshad@public121.com. Or Call US 924235720121.

investors.publicstorage.com

Public Storage - Home

Public Storage Advantage 3. Find Storage in Your Area. Reserve Online & Save more. Tools to Make it Easy. Packing and Storage Tips. Financial Reports - Annual Reports. Stock Information - Stock Quote. Corporate Governance and Directors. Minimum 20 minute delay. March 29, 2018. March 29, 2018. Public Storage Announces What a Joke! Public Storage Announces What a Joke! Public Storage Launches What a Joke! Public Storage Announces Be Our Valentine Video Contest Winners. 2017 Form 10-K (PDF 733 KB. Public St...

investors.pulsebiosciences.com

Investor Relations | Pulse Biosciences

160; 0.02. Data as of 01/13/17 4:00 pm ET. Data provided by Nasdaq. Minimum 15 minutes delayed. Pulse Biosciences Quarterly Nano-Pulse Stimulation (NPS) Update. Pulse Biosciences Announces First Clinical Use of the Proprietary PulseTx Platform in a Pilot Study in Dermatology. Pulse Biosciences Announces New Data That Reinforce Potential Immuno-Oncology Benefits of Nano-Pulse Stimulation Technology. There are currently no events scheduled. Stock Quote and Chart.

investors.qbsuisse.com

qB Suisse | smart power solutions

Introducing the new revolutionary qb energy supply of electricity for 8 per kWh and all hot water is free of charge in your home. A reduction of more than 70% in the energy costs for the average European home; qb energy is cutting-edge Disruptive Innovation. Click on a slide to reach the next one. QB Suisse will supply qb energy. Decentralized power to the global markets and cut the customer off the grid supply, forever! SWITCH on-line to have a qb energy. Service and SWITCH the customer on. Making a rea...